Last reviewed · How we verify

NCT04225663

A Meditation Intervention on Subconcussive Head Impacts

Completed NA Last updated 7 July 2023
What this trial tests

NA trial testing Guided Meditation in Head Injury Trauma in 27 participants. Completed in 1 July 2022.

Timeline
2 August 2021
Primary endpoint
1 June 2022
1 July 2022

Quick facts

Lead sponsorWake Forest University Health Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment27
Start date2 August 2021
Primary completion1 June 2022
Estimated completion1 July 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Wake Forest University Health Sciences

Who can join

Adults 13 to 25, any sex, with Head Injury Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to explore potential methods of rehabilitating changes observed from repetitive head impacts. Participation in this study will involve functional magnetic resonance (fMRI) imaging, aerobic testing, heart rate variability (HRV) wrist monitor, hypercapnia challenge, a meditation rehabilitation intervention, and filling out survey information concerning subjective well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Guided Meditation

Trials testing the same drug.

Other recruiting trials for Head Injury Trauma

Currently open trials in the same condition.

Other Wake Forest University Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04225663.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing